Pacific Bio (PACB) Misses Q1 EPS by 1c, Miss on Revenues

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $19.4 million versus the consensus estimate of $24.54 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c